⌘K

Home/Filings/4/0001209191-21-048540

4//SEC Filing

Collins Helen Louise 4

Accession 0001209191-21-048540

CIK 0001422143other

View on SEC.gov Company Profile

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 5:17 PM ET

Size

7.7 KB

Accession

0001209191-21-048540

Insider Transaction Report

Form 4

Period: 2021-07-28

Kura Oncology, Inc.KURA

Collins Helen Louise

Director

Transactions

Award
Option to purchase common stock
2021-07-28+46,000→ 46,000 total
Exercise: $18.98Exp: 2031-07-27→ Common Stock (46,000 underlying)
Award
Option to purchase common stock
2021-07-28+19,166→ 19,166 total
Exercise: $18.98Exp: 2031-07-27→ Common Stock (19,166 underlying)

Footnotes (2)

[F1]This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
[F2]This option vests in full on the one year anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1

filerCIK 0001701247

Filing Metadata

Form type: 4
Filed: Jul 28, 8:00 PM ET
Accepted: Jul 29, 5:17 PM ET
Size: 7.7 KB

View on SEC.gov